Neutrogena Oil Free Acne Stress Control Power Clear Scrub

Description

This oil-free formulation is designed for acne treatment, utilizing Neutrogena® salicylic acid as its active ingredient. The product features MICRO CLEAR® technology, which aids in treating acne even before it becomes visible. The Power-Clear Scrub is packaged in a 4.2 FL. OZ. (125 mL) container, providing an effective solution for managing acne stress.

Uses and Indications

This drug is indicated for the treatment of acne. It is effective in managing acne even before it becomes clinically apparent.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects noted.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse their face daily as part of their skincare regimen. The patient should begin by wetting the face with water. Following this, a suitable amount of the scrub should be applied to the face, which should be massaged gently in a circular motion. Care should be taken to avoid contact with the delicate eye area during application. After massaging, the scrub must be rinsed off thoroughly with water to ensure complete removal from the skin.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

• Contact with eyes should be avoided; if contact occurs, the affected area must be flushed thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In cases where irritation occurs, it is recommended to limit the use to one topical acne medication at a time to mitigate adverse effects.

Contact with the eyes should be strictly avoided. In the event of accidental contact, patients should be instructed to flush the eyes thoroughly with water to prevent potential damage.

This product must be kept out of reach of children. In the event of ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

It is important to note that this product contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight, increasing the risk of sunburn. Patients should be counseled to use a broad-spectrum sunscreen, wear protective clothing, and limit sun exposure while using this product and for at least one week following its discontinuation. Regular monitoring of skin condition is advisable to assess for any adverse reactions.

Side Effects

Patients using this product should be aware that it is for external use only. The use of this product may lead to skin irritation and dryness, particularly if another topical acne medication is used concurrently. In such cases, it is advised to use only one topical acne medication at a time to minimize the risk of irritation.

Contact with the eyes should be avoided; if contact occurs, it is essential to flush the eyes thoroughly with water. Additionally, this product contains an alpha hydroxy acid (AHA), which may increase the skin's sensitivity to the sun, raising the risk of sunburn. Therefore, patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using this product and for at least one week following its use.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact with a Poison Control Center should be made without delay.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil Free Acne Stress Control Power Clear Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of Neutrogena Oil-Free Acne Stress Control Power Clear Scrub during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering its use in pregnant patients. Healthcare professionals should exercise caution and consider the absence of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding or effects on breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. If contact occurs, patients should be advised to flush the eyes thoroughly with water to reduce the risk of irritation or injury.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid contact with the eyes; in the event of contact, they should flush the area thoroughly with water. Patients should be informed that the product contains an alpha hydroxy acid (AHA), which may increase skin sensitivity to sunlight and the risk of sunburn. It is recommended that patients use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil Free Acne Stress Control Power Clear Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)